Table 3.
Agent | Administration route | n |
Histamine-2-antagonist | Intermittent IV | 63 |
IV infusion | 13 | |
Oral | 27 | |
Feeding tube | 36 | |
Sucralfate | Oral | 13 |
Nasogastric tube | 20 | |
Omeprazole | Oral | 4 |
Nasogastric tube | 4 | |
Enteral tube | 2 | |
Other | 0 |
Responders were permitted to check more than one administration route for their institution's preferred agent. IV, intravenous.